Melinta Therapeutics

FDA approves new antifungal as concerns grow over drug-resistant fungus
FDA approves new antifungal as concerns grow over drug-resistant fungus
BioPharma Dive
FDA
Cidara Therapeutics
Melinta Therapeutics
antifungals
candidemia
candidiasis
Rezzayo
Flag link:
Go or no go? Vaccines and neurology up for discussion
Go or no go? Vaccines and neurology up for discussion
EP Vantage
FDA
Acadia Pharmaceuticals
Apellis Pharmaceuticals
AstraZeneca
Biogen
Biomarin
Cidara Therapeutics
Emergent BioSolutions
GSK
Incyte
Ionis Pharmaceuticals
Melinta Therapeutics
Mundipharma
Novartis
Pfizer
Pharming
Regeneron
Roche
vaccines
RSV
ALS
COVID-19
Flag link:
FDA advisers back Cidara and Melinta’s antifungal treatment
FDA advisers back Cidara and Melinta’s antifungal treatment
BioPharma Dive
FDA
Cidara Therapeutics
Melinta Therapeutics
antifungals
candidemia
candidiasis
rezafungin
Flag link:
Melinta Expands Antibiotics Lineup With $39M Tetraphase Acquisition
Melinta Expands Antibiotics Lineup With $39M Tetraphase Acquisition
Xconomy
Melinta Therapeutics
Tetraphase
M&A
antibiotics
Flag link:
As it happened: A bidding war for an antibiotic maker in a market that has ravaged its peers
As it happened: A bidding war for an antibiotic maker in a market that has ravaged its peers
Endpoints
antibiotics
M&A
Tetraphase
AcelRx
Melinta Therapeutics
La Jolla Pharmaceutical
Flag link:
Melinta's Bankruptcy Underlines Problems with the Antibiotics Market
Melinta's Bankruptcy Underlines Problems with the Antibiotics Market
BioSpace
Melinta Therapeutics
bankruptcy
antibiotics
Flag link:
Melinta’s Chapter 11 Auction Draws No Bids, Deerfield to Get Asset
Melinta’s Chapter 11 Auction Draws No Bids, Deerfield to Get Asset
Xconomy
Melinta Therapeutics
Chapter 11
bankruptcy
Flag link:
Melinta seeks buyout bids to secure escape from bankruptcy
Melinta seeks buyout bids to secure escape from bankruptcy
Fierce Biotech
Melinta Therapeutics
M&A
bankruptcy
Flag link:
Antibiotics maker Melinta files for Chapter 11 bankruptcy
Antibiotics maker Melinta files for Chapter 11 bankruptcy
Reuters
Melinta Therapeutics
Chapter 11
bankruptcy
antibiotics
Flag link:
FDA OKs new use for Melinta's Baxdela; shares down 26% premarket on potential capital raise
FDA OKs new use for Melinta's Baxdela; shares down 26% premarket on potential capital raise
Seeking Alpha
Melinta Therapeutics
FDA
Baxdela
community-acquired bacterial pneumonia
Flag link:
The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict
The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict
Yahoo/Benzinga
earnings
Eli Lilly
Alexion
Gilead Sciences
Biomarin
Edwards Lifesciences
Baxter International
Integra LifeSciences
Phathom Pharmaceuticals
IPOs
Foamix
Eton Pharmaceuticals
Melinta Therapeutics
Ligand Pharmaceuticals
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Merck
Keytruda
Melinta Therapeutics
Amag Pharmaceuticals
Palatin
Acer Therapeutics
Sanofi
Regeneron
Alexion
Pfizer
Roche
Navidea Biopharmaceuticals
Ascendis Pharma
Scholar Rock
Adaptive Biotechnologies
BridgeBio
IPOs
G Medical Innovations
Karuna
Morphic Therapeutics
Flag link:
In starved antibiotic field, Melinta soars as FDA grants speedy drug review
In starved antibiotic field, Melinta soars as FDA grants speedy drug review
Endpoints
Melinta Therapeutics
antibiotics
Baxdela
community-acquired bacterial pneumonia
FDA
priority review
Flag link:
John Johnson is back trying his hand as a turnaround artist for a troubled biotech. Can he win this time?
John Johnson is back trying his hand as a turnaround artist for a troubled biotech. Can he win this time?
Endpoints
Melinta Therapeutics
John Johnson
Pharma CEOs
Flag link:
Several CEOs and 17 years later, Melinta scores an FDA OK for its antibiotic
Several CEOs and 17 years later, Melinta scores an FDA OK for its antibiotic
Endpoints
Melinta Therapeutics
FDA
antibiotics
delafloxacin
Baxdela
Flag link:
Antibiotics developer Melinta lands a $70M round for PhIII development
Antibiotics developer Melinta lands a $70M round for PhIII development
Fierce Biotech
Melinta Therapeutics
antibiotics
delafloxacin
Flag link:
How the Game Changed Against Big Pharma - Creating New Opportunities
How the Game Changed Against Big Pharma - Creating New Opportunities
Forbes
Merck
Pfizer
Eli Lilly
Big Pharma
Sanofi
Roche
GSK
Abbott Laboratories
Melinta Therapeutics
antibiotics
delafloxacin
Flag link: